Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides.
Towards an HIV cure: a global scientific strategy.
Copy number variation of KIR genes influences HIV-1 control.
Thymidine analogue excision and discrimination modulated by mutational complexes including single amino acid deletions of Asp-67 or Thr-69 in HIV-1 reverse transcriptase.
Optimal antiviral switching to minimize resistance risk in HIV therapy.
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
Definition of the viral targets of protective HIV-1-specific T cell responses.
Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
A therapeutic dendritic cell-based vaccine for HIV-1 infection.
Impact of phenotype definition on genome-wide association signals: empirical evaluation in human immunodeficiency virus type 1 infection.